Drug Combination for Treatment of Proliferative Diseases
Nowak-sliwinska, Patrycja; Dyson, Paul; Griffioen, Arjan; Weiss, Andrea; Van Den Bergh, Hubert; Ding, Xianting
2017

Abstract

Angiogenesis inhibitory drug combination obtained according to a specific algorithm, preferably a FSC, in which an initial combination of drugs is iteratively adjusted. The drug combination according to the invention may advantageously comprise a RAPTA-C compound. In a more specific case the combination comprises RAPTA-C and eriotinib.

Details

Title Drug Combination for Treatment of Proliferative Diseases
Author(s) Nowak-sliwinska, Patrycja ; Dyson, Paul ; Griffioen, Arjan ; Weiss, Andrea ; Van Den Bergh, Hubert ; Ding, Xianting
Date 2017
Keywords
Note Alternative title(s) : (de) Arzneimittelkombination zur behandlung proliferativer krankheiten (fr) Association de médicaments pour le traitement de maladies prolifératives (en) Drug combination for treatment of proliferative diseases
Other identifier(s) EPO Family ID: 52875103
Patent number(s) US2017014372 (A1)
EP3116485 (A2)
WO2015136061 (A3)
WO2015136061 (A2)
Laboratories ISIC
TTO
Record Appears in Scientific production and competences > SB - School of Basic Sciences > ISIC - Institute of Chemical Sciences and Engineering > UNATTRIBUTED-ISIC - ISIC - Unattributed publications
Scientific production and competences > Non-academic units > TTO - Technology Transfer Office
Work produced at EPFL
Patents
Record creation date 2017-05-02

Actions